Insulet Prices IPO

Insulet Corp., a Bedford, Mass.-based maker of wireless glucose pumps for diabetics, priced 7.7 million common shares at $15 per share, for an IPO take of approximately $115.5 million. It had previously filed to sell 6.7 million shares at between $14 and $16 a piece. It will trade on the Nasdaq under ticker symbol PODD, while JP Morgan and Merrill Lynch served as co-lead underwriters. Insulet had raised $120.2 million in total VC funding since its 2000 inception, from firms like Prism VentureWorks, Versant Ventures, Alta Partners, The Kaufmann Fund, MedVenture Associates, Pequot Capital, Oakwood Medical Investors, Orbimed Advisors, Red Abbey Venture Partners, SV Life Sciences, SightLine Partners and TIAA-CREF.